At Alfa we value sustainable and long-term partnerships

Alfa is a medium-sized family business with headquarters in Heppenheim, Germany and strong roots in the EU, Asia and African markets.

We are specialized in innovative and generic pharmaceutical and nutraceutical products. Our focus lies on products with sound scientific evidence for the prevention and treatment of diabetic comorbidities, oncology, neurological diseases, heart disease, COPD, Mental Health, Dermatology, and Eye conditions as well as for women’s health.

With our own sales force and highly qualified employees, we visit doctors and pharmacists worldwide.

We are open to exploring strategic partnerships with a focus on 

  • Licensing
  • Co-development, and
  • Co-commercialization.

 Our current therapeutic areas of interest are: 

  • Anti-infective
  • Cardiovascular system
  • Dermatology
  • Diabetes
  • Immunology
  • Oncology
  • Ophthalmological
  • Pain Management and
  • Respiratory

European and growth market opportunities

With respect to the European markets, we are looking to market products that leverage our existing portfolio and commercial platforms. Whilst we are prioritizing products in the pre-registration and commercial stages, we are open to assisting new partners in obtaining late-stage drug approval in Europe and assisting in building a value-proposition for its pricing, market access and reimbursement. Region-wide deals are our bread and butter. However, we are also well versed in country-by-country distribution, co-marketing or co-promotion arrangements. We offer broad commercial coverage, and excellent relationships with members of our pharmaceutical network. 

Alfa’s growth market region includes the Middle East, Africa, LATAM and Asian markets. For these markets and others, we are looking to expand our range of products for our business partners to market and distribute. 

Please feel free to send us your opportunities through the email below. We are committed to providing timely feedback.